Science Explorer Back to mapMap
Institution · Sound Health Options

Most cited papers from Sound Health Options

What are the most cited papers from Sound Health Options?

The most cited paper from Sound Health Options is "Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection" (Gregory T. Everson et al., 2013), with 199 citations. Next come "Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid" (115) and "Daclatasvir Plus Peginterferon and Ribavirin Is Noninferior to Peginterferon and Ribavirin Alone, and Reduces the Duration of Treatment for HCV Genotype 2 or 3 Infection" (60).

Showing 13 of 13 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Efficacy of an Interferon- and Ribavirin-Free Regimen of Daclatasvir, Asunaprevir, and BMS-791325 in Treatment-Naive Patients With HCV Genotype 1 Infection Gregory T. Everson et al. · Gastroenterology Open access 30 Oct 2013 199
2 Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid Stephen R. Lee, Keith W. Kardos, Eugene R. Schiff et al. · Journal of Virological Methods 22 Dec 2010 115
3 Daclatasvir Plus Peginterferon and Ribavirin Is Noninferior to Peginterferon and Ribavirin Alone, and Reduces the Duration of Treatment for HCV Genotype 2 or 3 Infection Gregory J. Dore et al. · Gastroenterology Open access 13 Oct 2014 60
4 1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV Mark Sulkowski, Marc Bourlière, J.‐P. Bronowicki et al. · Journal of Hepatology Apr 2010 22
5 Practicing effectively in today's health system: teaching systems-based care. Marc L. Rivo, Dean R. Keller, Arianne Teherani et al. · PubMed 2004 22
6 1189 ONCE-DAILY NS5A INHIBITOR (BMS-790052) PLUS PEGINTERFERON-ALPHA-2A AND RIBAVIRIN PRODUCES HIGH RATES OF EXTENDED RAPID VIROLOGIC RESPONSE IN TREATMENT-NAIVE HCV-GENOTYPE 1 SUBJECTS: PHASE 2A TRIAL S. Pol, Greg T. Everson, R. Ghalib et al. · Journal of Hepatology Apr 2010 15
7 An artificial intelligence algorithm‐based smartphone application for daily cough monitoring Ji‐Su Shim, Min‐Hye Kim, Sang Min Lee et al. · Allergy 2 Jan 2023 13
8 Characterization of cylindrical ultrasonic transducers using acoustic holography Sergey A. Tsysar, Y. D. Sinelnikov, Oleg A. Sapozhnikov · Acoustical Physics 2011 10
9 A Win-Win Partnership Mary Lynn Pannen · Journal of Gerontological Social Work 10 May 2001 9
10 Cough Sounds Recorded via Smart Devices as Useful Non-Invasive Digital Biomarkers of Aspiration Risk: A Case Report Hye-Seon Kang, Eung-Gu Lee, Cheol-Ki Kim et al. · Sensors Open access 2 Dec 2021 3
11 Evaluation of proudP Dean Elterman, Naeem Bhojani, Kiwook Lee et al. · Canadian Urological Association Journal Open access 30 Aug 2024 2
12 Conflict Engagement for Individualized Education Program Team Members G. Ogden Abell · Language Speech and Hearing Services in Schools 26 Dec 2023 2
13 Building a Successful Private Care Management Company Mary Lynn Pannen · Lippincott s Case Management Sep 2004 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.